118684-32-5Relevant articles and documents
Adenosine receptor antagonists
-
Paragraph 0251-0252; 0254, (2020/12/15)
The invention provides a compound shown as a formula (I) and a pharmaceutical composition thereof. The compounds of formula (I) of the present invention are useful as adenosine receptor inhibitors, especially A2A and/or A2B inhibitors, for example, the product can be used for prevention or treatment of diseases associated with A2A and/or A2B activity or expression.
N-alkyl ammonia methylaniline and synthetic, and is used for its polymer anti-corrosion metal surface
-
Paragraph 0026; 0053, (2017/04/11)
The invention discloses N-alkyl aminomethyl aniline as well as synthesis and a polymer thereof and application of the N-alkyl aminomethyl aniline in metal surface anticorrosion. According to the characteristics that after the amine corrosion inhibitor is
A tetrameric hetero-octanuclear cyclic helicate formed from a bridging ligand with two inequivalent binding sites
Metherell,Ward
, p. 14281 - 14285 (2013/09/02)
A bis-bidentate bridging ligand H2L with inequivalent hard and soft binding sites (catecholate and pyrazolyl-pyridine, respectively) reacts with a mixture of Ti(iv) and Zn(ii) ions to afford an octanuclear heterometallic Ti4Zn4